Chart, page-71

Here's the 6 month Weekly chart post-consolidation.

Pretty consistent PA bar the May-June rout and ASX tax loss selling. Recovered strongly since the 23 July low of 25 cents.

Clear reluctance at the moment to break upper resistance band @ 42 - 45 cents.

Barring May-June sell down, seems to be good support since relist @ 35 cents.

Tracking the purple 20EMA and green 12EMA nicely.
Longer term 50-100-200EMA's all moving in the right direction.

I still think this shows the market taking a wait and see to FDA clearance. Understandable, but not necessarily justified. As Craig says, they've done this before, it's a predicate device not a new drug and it's a Clearance not Approval.

Craig indicated the next comms from FDA could be circa 30 days from the last one (when CDX answered all the questions), which he said put that in the next couple of weeks or so. A clean bill of health with no adverse comments should see continuation of the uptrend and the beginning of a rerate.